Avista Requests Natural Gas Rate Decrease for Oregon

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
99
Avista Requests Natural Gas Rate Decrease for Oregon Customers in Annual Cost Adjustment Filings

Request reflects change in the wholesale cost of natural gas included in customer rates

SPOKANE, Wash., July 27, 2018 (GLOBE NEWSWIRE) -- Avista’s (NYSE: AVA) customers in Oregon would see a decrease in their natural gas rates effective Nov. 1, 2018 if the Public Utility Commission of Oregon (OPUC or Commission) approves the company’s annual rate adjustment filings. These filings have no impact on the company’s earnings and are not related to the proposed acquisition of Avista by Hydro One.

Purchased Gas Cost Adjustment (PGA) The first rate adjustment is Avista’s Purchased Gas Cost Adjustment (PGA). PGAs are filed each year to balance the actual cost of wholesale natural gas purchased by Avista to serve customers with the amount included in rates. This includes natural gas commodity costs as well as the costs associated with transporting natural gas on interstate pipelines to Avista’s local distribution system. If approved, Avista’s request is designed to decrease natural gas revenues by $3.0 million or 3.2 percent.

This is the second reduction in natural gas commodity costs this year, with the first reduction approved in late January 2018.  Since that filing, natural gas commodity costs have continued to remain low due to high production levels of natural gas and an abundance of natural gas in storage.  

About 30 percent of an Avista natural gas customer's bill in Oregon is the combined cost of purchasing natural gas on the wholesale market and transporting it to Avista's system. These costs fluctuate up and down based on market prices, and are not marked up by Avista. The remaining 70 percent covers the cost of delivering the natural gas -- the equipment and people needed to provide safe and reliable service.

Natural Gas Decoupling The second rate adjustment is related to Avista’s natural gas decoupling mechanism. Decoupling is a mechanism designed to break the link between a utility’s revenues and customers’ energy usage. Avista’s actual revenue, based on therm sales, will vary, up or down, from the level included in a general rate case and approved by the Commission. This could be caused by changes in weather, energy conservation or the economy. Generally, under decoupling natural gas revenues are adjusted each month based on the number of customers, rather than therm sales. The difference between revenues based on sales and revenues based on the number of customers is surcharged or rebated to customers beginning in the following year.

If approved, Avista’s request is designed to decrease natural gas revenues by $5.1 million or 5.4 percent. This rate adjustment is driven primarily by a higher level of customer usage in 2017 than the level of usage included in the development of customer rates.

Additional Filings Three additional filings that were made relate to the amortization of prior demand side management programs, recovering costs associated with residential bank fees, and intervenor funding.  If approved, the net impact of these three filings is a reduction of approximately $54,000 or 0.06 percent.

Customer Bills If the five requests are approved, Avista residential customers using an average of 47 therms per month could expect their bill to decrease by $4.73, or 8.6 percent, for a revised monthly bill of $50.16 beginning Nov. 1, 2018. Overall, Avista’s natural gas revenues would decrease by $8.1 million or 8.6 percent.

The percentage change for natural gas customers varies by rate schedule and depends on how much energy a customer uses.

Avista serves approximately 99,000 natural gas customers in Oregon.

About Avista Corp. Avista Corp. is an energy company involved in the production, transmission and distribution of energy as well as other energy-related businesses. Avista Utilities is our operating division that provides electric service to 385,000 customers and natural gas to 350,000 customers. Its service territory covers 30,000 square miles in eastern Washington, northern Idaho and parts of southern and eastern Oregon, with a population of 1.6 million. Alaska Energy and Resources Company is an Avista subsidiary that provides retail electric service in the city and borough of Juneau, Alaska, through its subsidiary Alaska Electric Light and Power Company . Avista stock is traded under the ticker symbol "AVA."  For more information about Avista, please visit www.avistacorp.com .

This news release contains forward-looking statements regarding the company’s current expectations. Forward-looking statements are all statements other than historical facts. Such statements speak only as of the date of the news release and are subject to a variety of risks and uncertainties, many of which are beyond the company’s control, which could cause actual results to differ materially from the expectations. These risks and uncertainties include, in addition to those discussed herein, all of the factors discussed in the company’s Annual Report on Form 10-K for the year ended Dec. 31, 2017 and the Quarterly Report on Form 10-Q for the quarter ended March 31, 2018.

SOURCE: Avista Corporation

To unsubscribe from Avista’s news release distribution, send a reply message to lena.funston@avistacorp.com

Contact:                                                                                 Media: Casey Fielder (509) 495-4916 casey.fielder@avistacorp.com Investors: Lauren Pendergraft (509) 495-2998 lauren.pendergraft@avistacorp.com   Avista 24/7 Media Access (509) 495-4174

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 311

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 138

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 627

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 58

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 357

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 108

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 358

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 559

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading

Top 5 Most Recently Viewed Articles

Assessing TJX Companies Inc: Market Sentiment and Performance

Updated Category News Views 199

Understanding TJX Companies Inc's Market Dynamics TJX Companies Inc (NYSE: TJX) is currently navigating an intriguing landscape in the stock market, characterized by an increase in short interest. Notably, the short interest as a percentage of float has surged by 6.82% since the latest report, with approximately 15.68 million shares now sold short. This accounts for 1.41%...

Continue Reading
Refresco Teamsters Achieve Historic Contractual Victory

Updated Category News Views 337

Historic Contract Ratified by Teamsters Local 767 Members of Teamsters Local 767 have made headlines with their recent contract ratification that promises significant improvements for the workers of Refresco. An overwhelming majority of 93 percent voted in favor of this new agreement, showcasing the unity and commitment of the union members. Support for Employees The...

Continue Reading
MAP Medical and Metrix-Secure Team Up for Enhanced Healthcare

Updated Category News Views 133

MAP Medical Partners with Metrix-Secure for Enhanced Services MAP Medical has officially partnered with Metrix-Secure, a recognized leader in the medical supply industry. This collaboration empowers MAP Medical to serve as an authorized distributor, providing quality medical supply solutions to a wide array of healthcare facilities. Enhancing Patient Care with Reliable...

Continue Reading
Investors Show Interest in Unusual Options for Marriott

Updated Category News Views 153

Insights into Unusual Options Activity for Marriott International Recently, there has been a notable surge in bearish sentiment among investors concerning Marriott International (NASDAQ: MAR). This shift in attitude is essential for retail traders to understand as it may indicate changes in the market landscape. These trading patterns were identified through a publicly...

Continue Reading
Caribou Biosciences Investors Have Legal Avenues Available

Updated Category News Views 135

Opportunity for Investors of Caribou Biosciences For those who invested in Caribou Biosciences, Inc. (NASDAQ: CRBU), an exciting opportunity has emerged concerning potential legal claims. The Rosen Law Firm, recognized for its dedication to investor rights, is actively reminding purchasers of Caribou securities of their rights. If you bought securities between July 14,...

Continue Reading